{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:16:00Z","timestamp":1790709360227,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T00:00:00Z","timestamp":1398816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s12032-014-0970-z","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T16:24:42Z","timestamp":1398788682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC"],"prefix":"10.1007","volume":"31","author":[{"given":"Xiaolu","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,30]]},"reference":[{"issue":"2","key":"970_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"970_CR2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"970_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpg.2004.10.004","volume":"19","author":"KA McGlynn","year":"2005","unstructured":"McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2005;19(1):3\u201323.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"9","key":"970_CR4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","volume":"6","author":"PA Farazi","year":"2006","unstructured":"Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6(9):674\u201387.","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 1","key":"970_CR5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1478-3231.2010.02395.x","volume":"31","author":"S Faivre","year":"2011","unstructured":"Faivre S, Bouattour M, Raymond E. Novel molecular therapies in hepatocellular carcinoma. Liver Int. 2011;31(Suppl 1):151\u201360.","journal-title":"Liver Int"},{"issue":"4","key":"970_CR6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ng0802-339","volume":"31","author":"SS Thorgeirsson","year":"2002","unstructured":"Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002;31(4):339\u201346.","journal-title":"Nat Genet"},{"key":"970_CR7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2407-11-73","volume":"11","author":"Y Soini","year":"2011","unstructured":"Soini Y, et al. Transcription factors zeb1, twist and snai1 in breast carcinoma. BMC Cancer. 2011;11:73.","journal-title":"BMC Cancer"},{"issue":"3","key":"970_CR8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/pmic.200900819","volume":"11","author":"LP Li","year":"2011","unstructured":"Li LP, et al. Subcellular proteomics revealed the epithelial-mesenchymal transition phenotype in lung cancer. Proteomics. 2011;11(3):429\u201339.","journal-title":"Proteomics"},{"issue":"22","key":"970_CR9","doi-asserted-by":"crossref","first-page":"7430","DOI":"10.1158\/1078-0432.CCR-08-0935","volume":"14","author":"A Soltermann","year":"2008","unstructured":"Soltermann A, et al. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res. 2008;14(22):7430\u20137.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"970_CR10","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1158\/1535-7163.MCT-10-0917","volume":"10","author":"F Zijl van","year":"2011","unstructured":"van Zijl F, et al. A human model of epithelial to mesenchymal transition to monitor drug efficacy in hepatocellular carcinoma progression. Mol Cancer Ther. 2011;10(5):850\u201360.","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"970_CR11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/08941939.2010.542272","volume":"24","author":"ZY Yi","year":"2011","unstructured":"Yi ZY, et al. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in hepatocellular carcinoma cells. J Invest Surg. 2011;24(2):67\u201376.","journal-title":"J Invest Surg"},{"issue":"6","key":"970_CR12","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1349-7006.2010.01536.x","volume":"101","author":"J Kim","year":"2010","unstructured":"Kim J, et al. Epithelial-mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma. Cancer Sci. 2010;101(6):1521\u20138.","journal-title":"Cancer Sci"},{"issue":"6","key":"970_CR13","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119(6):1420\u20138.","journal-title":"J Clin Invest"},{"issue":"6","key":"970_CR14","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1083\/jcb.108.6.2435","volume":"108","author":"J Behrens","year":"1989","unstructured":"Behrens J, et al. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell\u2013cell adhesion. J Cell Biol. 1989;108(6):2435\u201347.","journal-title":"J Cell Biol"},{"issue":"5","key":"970_CR15","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3892\/or_00000343","volume":"21","author":"S Okamoto","year":"2009","unstructured":"Okamoto S, et al. Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cysts. Oncol Rep. 2009;21(5):1209\u201314.","journal-title":"Oncol Rep"},{"issue":"5","key":"970_CR16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, et al. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871\u201390.","journal-title":"Cell"},{"issue":"4","key":"970_CR17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4132\/KoreanJPathol.2012.46.4.341","volume":"46","author":"NH Myong","year":"2012","unstructured":"Myong NH. Loss of E-cadherin and acquisition of vimentin in epithelial-mesenchymal transition are noble indicators of uterine cervix cancer progression. Korean J Pathol. 2012;46(4):341\u20138.","journal-title":"Korean J Pathol"},{"issue":"30","key":"970_CR18","doi-asserted-by":"crossref","first-page":"22089","DOI":"10.1074\/jbc.M700998200","volume":"282","author":"A Kaimori","year":"2007","unstructured":"Kaimori A, et al. Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem. 2007;282(30):22089\u2013101.","journal-title":"J Biol Chem"},{"issue":"18","key":"970_CR19","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1073\/pnas.0902368106","volume":"106","author":"F Guan","year":"2009","unstructured":"Guan F, Handa K, Hakomori SI. Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines. Proc Natl Acad Sci USA. 2009;106(18):7461\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"970_CR20","doi-asserted-by":"crossref","first-page":"e21539","DOI":"10.1371\/journal.pone.0021539","volume":"6","author":"M Vaid","year":"2011","unstructured":"Vaid M, Singh T, Katiyar SK. Grape seed proanthocyanidins inhibit melanoma cell invasiveness by reduction of PGE2 synthesis and reversal of epithelial-to-mesenchymal transition. PLoS ONE. 2011;6(6):e21539.","journal-title":"PLoS ONE"},{"issue":"1","key":"970_CR21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2353\/ajpath.2010.090747","volume":"177","author":"Y Sato","year":"2010","unstructured":"Sato Y, et al. Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1\/Snail activation aggravates invasive growth of cholangiocarcinoma. Am J Pathol. 2010;177(1):141\u201352.","journal-title":"Am J Pathol"},{"issue":"10","key":"970_CR22","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1158\/0008-5472.CAN-08-2837","volume":"69","author":"A Ghoul","year":"2009","unstructured":"Ghoul A, et al. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells. Cancer Res. 2009;69(10):4260\u20139.","journal-title":"Cancer Res"},{"issue":"5","key":"970_CR23","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1158\/0008-5472.CAN-10-2350","volume":"71","author":"JF Lo","year":"2011","unstructured":"Lo JF, et al. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Res. 2011;71(5):1912\u201323.","journal-title":"Cancer Res"},{"issue":"2","key":"970_CR24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10549-010-0734-1","volume":"124","author":"FT Martin","year":"2010","unstructured":"Martin FT, et al. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat. 2010;124(2):317\u201326.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"970_CR25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/hep.23311","volume":"51","author":"T Sun","year":"2010","unstructured":"Sun T, et al. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology. 2010;51(2):545\u201356.","journal-title":"Hepatology"},{"issue":"5","key":"970_CR26","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.23221","volume":"50","author":"MH Yang","year":"2009","unstructured":"Yang MH, et al. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology. 2009;50(5):1464\u201374.","journal-title":"Hepatology"},{"issue":"6","key":"970_CR27","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ejcts.2011.01.023","volume":"39","author":"G Wang","year":"2011","unstructured":"Wang G, et al. A comparison of Twist and E-cadherin protein expression in primary non-small-cell lung carcinoma and corresponding metastases. Eur J Cardiothorac Surg. 2011;39(6):1028\u201332.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"970_CR28","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2353\/ajpath.2009.080983","volume":"175","author":"G Zheng","year":"2009","unstructured":"Zheng G, et al. Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells. Am J Pathol. 2009;175(2):580\u201391.","journal-title":"Am J Pathol"},{"issue":"6","key":"970_CR29","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2(6):442\u201354.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"970_CR30","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1053\/j.gastro.2006.08.041","volume":"131","author":"U Stein","year":"2006","unstructured":"Stein U, et al. The metastasis-associated gene S100A4 is a novel target of beta-catenin\/T-cell factor signaling in colon cancer. Gastroenterology. 2006;131(5):1486\u2013500.","journal-title":"Gastroenterology"},{"issue":"6","key":"970_CR31","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/(SICI)1097-0215(19960917)67:6<831::AID-IJC13>3.0.CO;2-4","volume":"67","author":"M Grigorian","year":"1996","unstructured":"Grigorian M, et al. Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int J Cancer. 1996;67(6):831\u201341.","journal-title":"Int J Cancer"},{"issue":"12","key":"970_CR32","first-page":"3386","volume":"63","author":"C Xue","year":"2003","unstructured":"Xue C, et al. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res. 2003;63(12):3386\u201394.","journal-title":"Cancer Res"},{"issue":"14","key":"970_CR33","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1158\/0008-5472.CAN-07-0440","volume":"67","author":"PC Mahon","year":"2007","unstructured":"Mahon PC, et al. S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer. Cancer Res. 2007;67(14):6786\u201395.","journal-title":"Cancer Res"},{"issue":"18","key":"970_CR34","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","volume":"68","author":"A Satelli","year":"2011","unstructured":"Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011;68(18):3033\u201346.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"970_CR35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrc1251","volume":"4","author":"MA Hollingsworth","year":"2004","unstructured":"Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer. 2004;4(1):45\u201360.","journal-title":"Nat Rev Cancer"},{"issue":"16","key":"970_CR36","first-page":"5011","volume":"63","author":"KG Kohlgraf","year":"2003","unstructured":"Kohlgraf KG, et al. Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line. Cancer Res. 2003;63(16):5011\u201320.","journal-title":"Cancer Res"},{"issue":"4","key":"970_CR37","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2559.2009.03247.x","volume":"54","author":"MA Kim","year":"2009","unstructured":"Kim MA, et al. Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathology. 2009;54(4):442\u201351.","journal-title":"Histopathology"},{"issue":"1","key":"970_CR38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3748\/wjg.v17.i1.69","volume":"17","author":"LY Huang","year":"2011","unstructured":"Huang LY, et al. S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer. World J Gastroenterol. 2011;17(1):69\u201378.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"970_CR39","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1093\/carcin\/bgt282","volume":"34","author":"Y Toiyama","year":"2013","unstructured":"Toiyama Y, et al. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer. Carcinogenesis. 2013;34(11):2548\u201357.","journal-title":"Carcinogenesis"},{"issue":"5","key":"970_CR40","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00432-013-1376-6","volume":"139","author":"N Yamashita","year":"2013","unstructured":"Yamashita N, et al. Vimentin as a poor prognostic factor for triple-negative breast cancer. J Cancer Res Clin Oncol. 2013;139(5):739\u201346.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"970_CR41","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2559.2008.02971.x","volume":"52","author":"XY Zhong","year":"2008","unstructured":"Zhong XY, et al. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer. Histopathology. 2008;52(5):560\u20138.","journal-title":"Histopathology"},{"issue":"4","key":"970_CR42","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.humpath.2006.10.004","volume":"38","author":"Z Zhang","year":"2007","unstructured":"Zhang Z, et al. Significance of TWIST expression and its association with E-cadherin in bladder cancer. Hum Pathol. 2007;38(4):598\u2013606.","journal-title":"Hum Pathol"},{"issue":"8","key":"970_CR43","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/bjs.6635","volume":"96","author":"H Ando","year":"2009","unstructured":"Ando H, et al. Prognostic significance of the expression of MUC1 and collagen type IV in advanced gastric carcinoma. Br J Surg. 2009;96(8):901\u20139.","journal-title":"Br J Surg"},{"issue":"3\u20134","key":"970_CR44","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10555-013-9423-y","volume":"32","author":"J Deng","year":"2013","unstructured":"Deng J, et al. The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression. Cancer Metastasis Rev. 2013;32(3\u20134):535\u201351.","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"970_CR45","first-page":"351","volume":"40","author":"ZS Li","year":"2011","unstructured":"Li ZS, Li Q. The latest 2010 WHO classification of tumors of digestive system. Zhonghua Bing Li Xue Za Zhi. 2011;40(5):351\u20134.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"4","key":"970_CR46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/jcp.2010.085142","volume":"64","author":"J Huang","year":"2011","unstructured":"Huang J, et al. Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma. J Clin Pathol. 2011;64(4):343\u20138.","journal-title":"J Clin Pathol"},{"issue":"8","key":"970_CR47","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0006-2952(00)00427-5","volume":"60","author":"B Boyer","year":"2000","unstructured":"Boyer B, Valles AM, Edme N. Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol. 2000;60(8):1091\u20139.","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"970_CR48","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","volume":"68","author":"TT Onder","year":"2008","unstructured":"Onder TT, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008;68(10):3645\u201354.","journal-title":"Cancer Res"},{"issue":"2","key":"970_CR49","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2353\/ajpath.2010.090526","volume":"176","author":"K Boye","year":"2010","unstructured":"Boye K, Maelandsmo GM. S100A4 and metastasis: a small actor playing many roles. Am J Pathol. 2010;176(2):528\u201335.","journal-title":"Am J Pathol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0970-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-014-0970-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0970-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:31:51Z","timestamp":1559442711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-014-0970-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,30]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["970"],"URL":"https:\/\/doi.org\/10.1007\/s12032-014-0970-z","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,30]]},"article-number":"970"}}